Skip to main content

Completed Pulmonary Hypertension Trials


AC-055-503 - OPUS Registry

US-based, observational, drug registry of Opsumit® (macitentan) new users in clinical practice

     More Information


AC-0550510 - OrPHeUS

Multicenter, retrospective chart review of first-time Opsumit® (macitentan) users in the United States

     More Information 

CXA-10-301 - PRIMEx

Phase 2 Multicenter, Double-Blind, Placebo Controlled, Efficacy, Safety, and Pharmacokinetic Study of 2 Doses of CXA-10 on Stable Background Therapy in Subjects with Pulmonary Arterial Hypertension (PAH)

     More Information    


CXA-10-2302 - PRIMEx OLE

A Phase 2, Multi-Center, Open-Label Study to Evaluate Long-term Safety and Efficacy of CXA-10 in Subjects with Pulmonary Arterial Hypertension on Stable Background Therapy: Extension to Study CXA-10-301

     More Information 

LTI-301 - INSPIRE

A Phase 3 Open-label, Multicenter Study to Evaluate the Long-term Safety and Tolerability of Inhaled LIQ861(Treprostinil) in Pulmonary Arterial Hypertension (WHO Group 1) Patients

     More Information


REPLACE - Riociguat rEplacing PDE-5i therapy evaLuated Against Continued PDE-5i thErapy

A prospective, randomized, international, multicenter, double-arm, controlled, open-label study of Riociguat in patients with pulmonary arterial hypertension (PAH) who are on a stable dose of phosphodiesterase-5 inhibitors (PDE-5i) with or without endothelin receptor antagonist (ERA), but not at treatment goal.

     More Information


RIN-PH-201 - INCREASE

A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects with Pulmonary Hypertension due to Parenchymal Lung Disease

     More Information


TDE-HF-301 - SouthPaw

A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects with Pulmonary Hypertension (PH) in Heart Failure with Preserved Ejection Fraction (HFpEF)

     More Information


TDE-HF-302 - SouthPaw OLE

An Open-label Extension Study of Oral Treprostinil in Subjects with Pulmonary Hypertension (PH) Associated with Heart Failure with Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301

     More Information 


U.S. CTEPH Registry

The U.S. CTEPH Registry is a multicenter, observational, U.S.-based study of the clinical course and treatment of patients diagnosed with chronic thromboembolic pulmonary hypertension (CTEPH), WHO Group IV Classification for Pulmonary Hypertension.

     More Information

Last modified: Jun 14, 2021
ID=x36920